Laronidase Terminated Phase 4 Trials for Mucopolysaccharidosis Type I (MPS I) / Hurler-Scheie Syndrome / Scheie Syndrome / Mucopolysaccharidosis IH Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00418821A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed Infants